Rene has a wide range of knowledge and experience in conceptualising innovative commercial marketing and distribution strategies to drive market expansion and business development. Under his leadership the team accomplished defining Digital Solutions by researching patient experience and patient journeys to identify pain points that may benefit from implementing digital technology and/or services resulting in long-term sustained growth and profitability. These initiatives increase value of brand through determination of life cycle management requirements and the addition of services for caregiver, patients, and caregivers. Led large budgets and teams in a variety of matrix and independent organisations.

Rene has been leading and coaching high performing teams and utilizes patient and stakeholder focussed marketing research outcomes in decision-making to positively affect project outcomes with creative and innovative solutions. As a creative and organised individual with a passion for excellence, he listens to client’s needs, analysing and implementing best designed solutions. He has specific industry therapeutic area expertise in Neuroscience (Migraine, MS, Alzheimer’s, MCI, Parkinson, mood and anxiety disorders), Cardio-Vascular and Metabolic, Neuro-Immunology with a focus on supplementing Digital (Therapeutic) Solutions that improve profitability. Rene developed and implemented a Global Commercial Deliverable Architecture to enhance the commercial capabilities prior to significant planned launches and has launched 4 major pharmaceutical brands globally between 2013 and 2015. He has experience in reassessing scopes of development and commercial options and delivered strategic focused disease area plans and portfolio recommendations with or without integrated digital solutions or digital medicines.

My main focus areas in consulting for small to large pharmaceutical companies: • Create and/or Pressure test Global Product Strategies • Design Innovative Business Models • Develop Go to market Strategy, Launch and Pre-launch • Design and conduct Launch Readiness Reviews • Develop Digital medicines, therapeutics and Solutions, eHealth and Value-Added Services • Strategic Scenarios and Planning, • Global / Regional Forecasting, • International and local Market Access Strategy, • Brand Maximization and LoE strategy, LCM Strategy, • Patient Empowerment and Adherence, Specific Therapeutic Area Expertise: Neuroscience (Migraine, MS, Alzheimers, Parkinson, mood and anxiety disorders) CardioVascular and Metabolics, Ophtamology, Immunology, Gastro and Digital Therapeutic & Solutions

Founder of a Digital Health company developing a SaMD digital health application designed to support and enhance patient health literacy. It collects and tracks health data from wearables and provides users with informative content, aiming to foster better health choices. It is targeted towards individuals looking for supplementary health information and insights. My main focus areas in our management team: • Optimize design and development of our Digital Health Platform myAVOS for the UK, DACH and the USA • Launched myAVOS in the USA in 2023 • Partnerships realized with external partners: • Lead operations and provided strategic direction with full P&L • Hired and managed cross functional management team : CTO, CMO, CSO and external advisors, Alumni of: • Basel Day One – Cohort 2 • Creative Destruction Lab – Oxford University – Said School of Business • Biogen and EIT Health – NeuroTech Prize Finalist • KickStart Innovation 2023 Specific Therapeutic Area Expertise: Neuroscience (Migraine, MS, Alzheimers, Parkinson, mood and anxiety disorders) CardioVascular and Metabolics, Ophtamology, Immunology, Gastro and Digital Therapeutic & Solutions